Naproxen Sodium

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 59726-751
  • Package NDC 59726-751-20
  • Application number ANDA202807
  • SPL ID 2a68267b-0fa0-4b09-b8a8-15f11aaa71f9
  • SPL set ID 3bd60171-c073-441a-8d59-c85efee69e07
  • UNII 9TN87S3A3C
  • RxCUI 1112231

What the source publishes

Labeler
P & L Development, LLC
Active ingredients
Naproxen Sodium
Form
CAPSULE
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN OTC DRUG
Prescription
Non-prescription

Names this record is found by

Complete source data
us:fda:ndc:59726-751_2a68267b-0fa0-4b09-b8a8-15f11aaa71f9
{
  "name": "Naproxen Sodium",
  "splId": "2a68267b-0fa0-4b09-b8a8-15f11aaa71f9",
  "labels": [
    {
      "setId": "3bd60171-c073-441a-8d59-c85efee69e07",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3bd60171-c073-441a-8d59-c85efee69e07",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3bd60171-c073-441a-8d59-c85efee69e07"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "P & L Development, LLC",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "1 BOTTLE, PLASTIC in 1 BOX (59726-751-20)  / 20 CAPSULE in 1 BOTTLE, PLASTIC",
      "package_ndc": "59726-751-20",
      "identifierStatus": "well-formed",
      "marketing_end_date": "20261231",
      "marketing_start_date": "20201204"
    }
  ],
  "productId": "59726-751_2a68267b-0fa0-4b09-b8a8-15f11aaa71f9",
  "useDomain": "unknown",
  "dosageForm": "CAPSULE",
  "productNdc": "59726-751",
  "deaSchedule": null,
  "genericName": "Naproxen Sodium",
  "productType": "HUMAN OTC DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": "20261231",
  "activeIngredients": [
    {
      "name": "NAPROXEN SODIUM",
      "strength": "220 mg/1"
    }
  ],
  "applicationNumber": "ANDA202807",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20201204",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "non-prescription",
  "harmonizedIdentifiers": {
    "upc": [
      "0359726751209"
    ],
    "unii": [
      "9TN87S3A3C"
    ],
    "rxcui": [
      "1112231"
    ],
    "spl_set_id": [
      "3bd60171-c073-441a-8d59-c85efee69e07"
    ],
    "manufacturer_name": [
      "P & L Development, LLC"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": null
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:59726-751_2a68267b-0fa0-4b09-b8a8-15f11aaa71f9"